Loading
Every trade that managers of Sirtris Pharmaceuticals, Inc. disclose to SEC (Form 4) is tracked on this page. The past year has been quiet: not a single insider filing for Sirtris Pharmaceuticals, Inc. The previous disclosure was published on 30 May 2008.
Looking back to 2007, when coverage begins, insiders filed no purchases and 350 sales.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
25 of 402 declarations
Sirtris Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing drugs to treat age-related diseases. It leverages research on sirtuins to create innovative therapies.